By Izzy Wood (Drug Target Review)2023-06-08T15:00:39
Japanese researchers now reveal a new way of activating GPCR by triggering shape changes in the intracellular region of the receptor. This new process can help researchers design drugs with fewer or no side effects.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-03-28T11:38:32
Sponsored by Bio-Techne
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud